US Patent Issued to Terns Pharmaceuticals on Jan. 20 for "Thyroid hormone receptor beta agonist compounds" (California Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,791, issued on Jan. 20, was assigned to Terns Pharmaceuticals Inc. (Foster City, Calif.).

"Thyroid hormone receptor beta agonist compounds" was invented by Thorsten A. Kirschberg (Foster City, Calif.), Randall Halcomb (Foster City, Calif.), Yingzi Xu (Palo Alto, Calif.) and F. Anthony Romero (Redwood City, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compounds of formula (I), or tautomers thereof, or pharmaceutically acceptable salts of any of the foregoing, compositions of any of the foregoing, and methods of their preparation, and methods of agonizing THR beta and methods for treating disorders mediated by THR beta." ...